Navigation Links
Omthera Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/5/2011

BEDMINSTER, N.J., Jan. 5, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that Jerry Wisler, President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA on Thursday, January 13, 2011 at 10:30am PT.

About Omthera Pharmaceuticals, Inc.Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately-held, emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia.  Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.  The lead product candidate is Epanova, an Omega 3 fatty acid compound preparing to enter Phase III clinical development as a triglyceride-lowering adjunct therapy to diet in patients with very high triglycerides (greater than or equal to 500 mg/dL).  Future planned clinical trials for Epanova include patients with high triglycerides (greater than or equal to 200 mg/dL and less than or equal to 500 mg/dL) currently on statin therapy.  Omthera holds worldwide rights to Epanova.
For more information, please visit www.omthera.com.Media ContactRx Communications Group, LLCEric GoldmanVice President, Public Relations917-322-2563egoldman@rxir.com
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
2. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10
3. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
4. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
8. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
10. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
11. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 The Physician-Patient Alliance for Health & ... posted its first blog on July 27, 2011, " Is ... This post featured what happened to ... a grocery store in Goodhue, Minnesota . ... involving 20 others, who took turns pumping his chest. ...
(Date:7/27/2015)... , July 17, 2015 Research and ... of the "G-Protein Coupled Receptors Market: Global ... 2014 - 2022" report to their offering. ... been segmented based on of assay type, therapeutic ... GPCRs market has been categorized into six major ...
(Date:7/27/2015)... VANCOUVER, British Columbia and ...   DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... has accepted subscriptions from institutional and accredited investors ... million shares of common stock and 3.35 million ...
Breaking Medicine Technology:Physician-Patient Alliance for Health & Safety Turns 4 Years Old 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
... China, Jan. 20, 2011 /PRNewswire-Asia/ -- Winner Medical ... Medical") a leading manufacturer of medical dressings, medical ... PurCotton® products in China, today announced that one ... ("Huanggang Cotton"), was recently awarded a Cotton Processing ...
... 2011 BioMed Realty Trust, Inc. (NYSE: ... of its 2010 distributions as follows:Security Description: Common ... ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital ... , $0.140000 , $0.090527 , $0.049473 , $0.000000 ...
Cached Medicine Technology:Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 3BioMed Realty Trust Announces Tax Treatment of 2010 Distributions 2
(Date:7/27/2015)... ... July 28, 2015 , ... ... Skills and Innovative Techniques to Improve the Quality of Investigations , **Presented by ... , Inadequate investigations and CAPAs have been the #1 reason for 483 observations ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk ... regional brain volumes that may be early indicators of Alzheimer’s disease and dementia, ... know that vascular risk factors damage the brain and can result in cognitive ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... its VIP Woman of the Year Circle. She is recognized with this prestigious distinction ... women, boasting more than 700,000 members and over 200 operating Local Chapters. , “I’m ...
(Date:7/27/2015)... , ... July 28, 2015 , ... ... Gilda Baum- Lappe as a 2015 Professional Woman of the Year. Ms. ... largest, most-recognized networking organization of professional women in the country, spanning virtually every ...
(Date:7/27/2015)... ... 27, 2015 , ... The heroin epidemic is affecting the Charlotte in North ... 7th. The rate for heroin usage has continued to climb around the country in ... less expensive alternative for those with an addiction to prescription opiate medications. According to ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Joanne Saniewski, Principal of the Frontier School District's Big Tree Elementary, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3
... cite proprietary research, strategic planning and ... superior creative as keys to their success, INDIANAPOLIS, Jan. ... awards at the Consumer Health World Conference in,Chicago this fall, ... top honors in a national awards program., The Service ...
... Minority and low-income patients are less likely than those ... to post-surgery epidural pain relief, according to new research ... Medicine. The study, published recently in the journal Anesthesia ... may influence health care choices when access to care ...
... Institute for Brain Research will head an ambitious new ... supported by a $8.5M grant from the Ellison Medical ... are prominent experts in neuroimaging and human brain development. ... first appear in early childhood. Autism impairs social interactions ...
... Calif., Jan. 31 BioForm Medical,Inc. (Nasdaq: BFRM ) ... 2007, which is the Company,s second quarter of fiscal,year 2008. ... 31,2007 as compared to $11.8 million for the quarter ended ... net loss was $1.6 million for the,quarter ended December 31, ...
... Inc. (OTC Bulletin Board: ACPH) is pleased to ... Company,s application to,list its common stock on the ... commence trading on NASDAQ on February 4, 2008,under ... to join the growing list of specialty pharmaceutical,companies ...
... D Seniors Also Enjoy Broad Choice of,Prescription Drugs, ... issued the following statement on new budget,figures that report ... over the,next ten years than was estimated last summer:, ... beneficiaries,choice of prescription drugs. New budget documents show that ...
Cached Medicine News:Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 2Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 3Health News:African-Americans less likely to choose epidurals for postoperative pain relief 2Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 3Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 4Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 5Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 6Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 7Health News:Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: